Thus, Orai3 that has been identified as an independent prognostic marker of survival and metastasis in lung adenocarcinoma [22] can be also used as a future strategy in targeting CSCs subsets in CDDP resistant NSCLC tumors. The gene discussed is ORAI3; the disease is non-small cell lung carcinoma.